Patent · US Active

Prodrugs of fencamfamine

US10662146B2 · kind B2 · utility

2Cited by
3References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 13, 2016
Grant dateMay 26, 2020
Priority date
Expiry dateSep 13, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2602/42
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are pharmaceutical compositions with fencamfamine or fencamfamine related prodrug derivatives. The pharmaceutical compositions are for targeted therapeutic applications including, but not limited to, treating cancer-related fatigue, apathy in Alzheimer's Disease, major depression, and attention deficit-hyperactivity disorder. Also disclosed are methods of synthesizing the pharmaceutical compositions with fencamfamine or fencamfamine related prodrug derivatives.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.